Gwrthrychau elusennol
1) TO ALLEVIATE THE EFFECTS OF ATRIAL FIBRILLATION (KNOWN AS AF) AND PROVIDE SUPPORT AND INFORMATION TO THOSE WITH THIS CONDITION, PARTICULARLY WITH REGARD TO THE AVAILABLE TREATMENTS AND ACCESS TO THEM.
2) TO ADVANCE THE EDUCATION OF THE MEDICAL PROFESSION AND THE GENERAL PUBLIC ON THE SUBJECT OF AF AND ITS IMPLICATIONS FOR THE PATIENT AND THE FAMILY.
3) TO PROMOTE RESEARCH INTO THE DIAGNOSIS AND MANAGEMENT OF AF AND TO SUPPORT THE PUBLICATION OF THE RESULTS OF THIS RESEARCH.
